Mental Health Clinics in Menden, IA Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Purposely Patient, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 Pecan Lane Apt 3, Menden, IA 51553 Phone: 402-403-2800 |
News Archive
Low-dose lithium lowers involuntary motor movements in mouse model of Parkinson's disease
Low-dose lithium reduced involuntary motor movements - the troubling side effect of the medication most commonly used to treat Parkinson's disease (PD) - in a mouse model of the condition that is diagnosed in about 60,000 Americans each year. The third in a series of studies from the Andersen lab involving PD and low-dose lithium, the results add to mounting evidence that low-doses of the psychotropic drug could benefit patients suffering from the incurable, degenerative condition.
Michigan judge rules individual mandate in health law is constitutional
"A U.S. judge on Thursday upheld a key part of President Barack Obama's signature healthcare law that requires Americans to obtain coverage, rejecting a challenge by a conservative interest group. The Thomas More Law Center filed a lawsuit in Michigan the day Obama signed it into law. It argued that the provision requiring Americans buy coverage by 2014 under threat of penalty was beyond Congress' authority and an unconstitutional tax" (Pelofsky, 10/7).
Pathology of Krabbe's disease may provide insights on late-onset neurodegenerative diseases
A recent article suggests that an enzyme deficiency seen in the lysosomal storage disorder Krabbe's disease may point to new and contributing mechanisms underlying certain late-onset neurodegenerative diseases such as Parkinson's disease.
Good tidings for women on HRT
For many women struggling to deal with the symptoms of the menopause, the latest research on hormone replacement therapy (HRT) bears good tidings.
Positive results from Aeterna Zentaris' AEZS-108 Phase 2 study in ovarian cancer patients
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with platinum-resistant and taxane-pretreated ovarian cancer.
› Verified 6 days ago